Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (86)

« Back to Publications

Tetrahydropyrazolopyridinones as a Novel Class of Potent and Highly Selective LIMK Inhibitors.

Baldwin AG. et al, (2025), Journal of medicinal chemistry, 68, 17427 - 17456

Discovery of MDI-114215: A Potent and Selective LIMK Inhibitor To Treat Fragile X Syndrome.

Baldwin AG. et al, (2025), Journal of medicinal chemistry, 68, 719 - 752

Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε.

de Souza Gama FH. et al, (2024), Journal of medicinal chemistry, 67, 8609 - 8629

Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist

Balıkçı E. et al, (2024), Journal of Medicinal Chemistry, 67, 7245 - 7259

Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases.

Henderson SH. et al, (2024), European journal of medicinal chemistry, 269

Recent advances in the structural biology of tyrosine kinases.

Rygiel KA. and Elkins JM., (2023), Current opinion in structural biology, 82

Updated protein domain annotation of the PARP protein family sheds new light on biological function.

Suskiewicz MJ. et al, (2023), Nucleic acids research, 51, 8217 - 8236

Target 2035 – an update on private sector contributions

Ackloo S. et al, (2023), RSC Medicinal Chemistry, 14, 1002 - 1011

An open source plant kinase chemogenomics set.

Ercoli MF. et al, (2022), Plant direct, 6

Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity.

Collins R. et al, (2022), Journal of medicinal chemistry, 65, 13705 - 13713

Development of dihydropyrrolopyridinone-based PKN2/PRK2 chemical tools to enable drug discovery.

Scott F. et al, (2022), Bioorganic & medicinal chemistry letters, 60

Chemical Probes for Understudied Kinases: Challenges and Opportunities.

Serafim RAM. et al, (2022), Journal of medicinal chemistry, 65, 1132 - 1170

Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold.

Serafim RAM. et al, (2021), Journal of medicinal chemistry, 64, 13259 - 13278

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors.

Henderson SH. et al, (2021), Journal of medicinal chemistry, 64, 11709 - 11728

Structure-kinetic relationship reveals the mechanism of selectivity of FAK inhibitors over PYK2.

Berger B-T. et al, (2021), Cell chemical biology, 28, 686 - 698.e7

Load More

1
2
3
4
5
6